Non-Cirrhotic Portal Hypertension
8
5
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Freiburg TIPS Registry
Prediction of Portal Hypertension in Patients With CVID (CVID-pHT)
Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)
Non-invasive Tools for PSVD Diagnosis
Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India
Vienna Vascular Liver Disease Study
Hepatic Venous Pressure Gradient and Elastography in Porto-sinusoidal Vascular Disorder
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease